Psoriasis Serum
About: Psoriasis Serum - Human serum samples collected from clinically confirmed psoriasis donors. Ideal for biomarker discovery and autoantibody analysis.
| Lot Number | Condition | Volume | Race/Ethnicity | Age | Gender | Country of Collection | Medications | Vials | Price | Action |
|---|---|---|---|---|---|---|---|---|---|---|
| 77429 | Psoriasis | 1.0 ML | Hispanic/Latino | 49 | Female |
Skyrizi 150mg (injection) every 3 months
|
4 | $316.00 | ||
| 75203 | Psoriasis | 1.0 ML | Hispanic/Latino | 76 | Female |
Methotrexate
|
3 | $316.00 | ||
| 75687 | Psoriasis | 1.0 ML | Caucasian | 21 | Male |
54 mg Methylphenidate (brand name Concerta), once per day in the morning. For ADHD. 5 mg guanfacine (brand name Tenex). Twice per day. Once in the morning, once at night. For ADHD. 100 mg + 250 mg (250 mg) fluvoxamine (brand name Luvox) at night. For OCD. 25 mg metorprolol, once per day at night. For tachycardia. 40 mg atomoxetine (brand name Strattera) once per day at night. For ADHD. 5 mg estradiol valerate, subcutaneous, once per week on Saturdays. Gender-affirming hormone therapy.
|
7 | $316.00 | ||
| 74582 | Psoriasis | 1.0 ML | Caucasian | 50 | Female |
Losartan 50mg QD Flovent Inhaler HFA 220mcg BID Ventolin HFA 90mcg PRN Prenatal vitamins Calcium Munjaro
|
5 | $316.00 | ||
| 73165 | Psoriasis | 1.0 ML | Caucasian | 41 | Male |
Concerta 76mg QD Bupropion 300mg QD Venlaxin 150mg QD
|
3 | $316.00 | ||
| 69582 | Psoriasis | 1.0 ML | Caucasian | 51 | Female | 6 | $316.00 | |||
| 68572 | Psoriasis | 1.0 ML | Caucasian | 41 | Male |
Concerta 76mg QD Bupropion 300mg QD Venlaxin 150mg QD
|
6 | $316.00 | ||
| 68230 | Psoriasis | 1.0 ML | Hispanic/Latino | 30 | Female | 2 | $316.00 | |||
| 72226 | Psoriasis | 1.0 ML | African American Hispanic/Latino | 27 | Female |
Stelara
|
6 | $316.00 | ||
| 74700 | Psoriasis | 1.0 ML | Caucasian | 69 | Female |
Otezla 30 mg BID Bupropion 150 mg QD Fluoxetine 120 mg QD Atorvastatin 5 mg QD
|
3 | $316.00 |
Human Psoriasis Serum for Research
Our Psoriasis Serum is sourced from IRB-consented donors clinically diagnosed with psoriasis. Each sample is processed and frozen within 24 hours of collection to ensure consistency and high quality for characterizing systemic inflammation associated with psoriasis.
Product Features
- Collected from clinically confirmed psoriasis donors
- Research Use Only (RUO)
- IRB-approved protocols with documented consent
De-identified Donor Data
- Diagnosis confirmation
- Age, sex assigned at birth, and ethnicity
- Donor-reported allergy and infectious disease history
Applications
- Biomarker discovery for psoriasis
- Serum cytokine and protein profiling
- Therapeutic candidate screening and validation
Compliance and Quality Assurance
- IRB-approved and HIPAA-compliant protocols
- Electronic informed consent with 21 CFR Part 11 – compliant e-signatures
- Documentation support available for regulatory review
Ordering and Customization
Psoriasis serum is available in standard and custom volumes. For international orders or documentation requirements, please email learnmore@sanguinebio.com to ensure compatibility with your country’s regulations.
Protocols & Documentation
-
Download
Serum Isolation
Protocol for serum preparation from whole blood, including collection handling, clarification, and quality documentation.
-
Informed Consent Form (ICF)
Available upon request — confirms donor consent for research use and downstream commercialization.
Serum
Frequently Asked Questions
1 Answer
YES – All collections are conducted under IRB-approved protocols and electronic informed consent. Sanguine utilizes Advarra and WCG IRB for oversight.
1 Answer
YES – with the exception of GMP leukopaks, all our products are research use only (RUO).
1 Answer
Our complete catalog can be found here: https://sanguinebio.com/products/
1 Answer
Storage depends on sample type but often cryopreserved samples stored in liquid nitrogen can be stored for years.
1 Answer
Extensive customization is available. To discuss your project request a quote or email us at learnmore@sanguinebio.com.
1 Answer
Sanguine offers flexible prospective colleciton services to tailored to fit your research. For more information and request a quote, please see: https://sanguinebio.com/prospective-biospecimen-collection-services/
1 Answer
Timelines depend on condition, sample type, and I/E criteria but we often start collection within 2 weeks of signed agreement.
1 Answer
YES – we have in-stock inventory which can be found here https://sanguinebio.com/products/?pro_inventory=inventory. You can also email us at learnmore@sanguinebio.com as we continually get new samples in our inventory.
1 Answer
Each sample from a different individual – Unique donor means each sample comes from a different person, ensuring biological diversity in your study.
1 Answer
YES – Unique donors can be specified and guaranteed based on your requirements.
1 Answer
For information about sample quality, please see: https://sanguinebio.com/quality-and-compliance/
1 Answer
YES – “IRB-approved collection protocols” and IRB approval documentation available upon request. Sanguine utilizes two internationally-recognized IRBs (Advarra and WCG IRB) for review and approval.
Ask a Question
Need a custom Serum cohort?
Our scientific team can scope prospective collections with donor-specific I/E criteria, typically starting within 2 weeks of agreement.